Award recordCONTRACT

ACORDA THERAPEUTICS, INC.

PIID VA24115J0755· VHA· 241-NETWORK CONTRACT OFFICE 01 (36C241)· 6505 · DRUGS AND BIOLOGICALS· FY2015· $120,673 net obligations· UEI R5D3FUPFFPK4· NY

Description

DECREASE TO CLOSE OUT ORDER. DALFAMPRIDINE 10MG SA TAB

Base award description: DALFAMPRIDINE 10MG SA TAB

First action · last action
2015-02-23 · 2016-12-21
Transactions
2
First transaction's obligation
$201,121
Base + all options value (sum of deltas)
$120,673
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
NO SET ASIDE USED.
Offers received
3
SDVOSB flag on record
No
Parent IDV
V797P5233B
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING

Modification chain · 2 transactions

Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.

$201,121$0Base award · 2015-02-23 · this action $201,121 · running total $201,121Modification P00001 · 2016-12-21 · this action -$80,448 · running total $120,673
  • Base2015-02-23+$201,121= $201,121
  • Mod P000012016-12-21-$80,448= $120,673
TransactionAction dateThis action (delta)Running totalDescription on this transaction
Base2015-02-23+$201,121$201,121DALFAMPRIDINE 10MG SA TAB
Mod P00001· CLOSE OUT2016-12-21−$80,448$120,673DECREASE TO CLOSE OUT ORDER. DALFAMPRIDINE 10MG SA TAB

Related awards · 11

Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.

Other VA awards to the same recipient (UEI R5D3FUPFFPK4)

AwardOffice · PSC / listingNet obligationsFY
36C77024N0067NATIONAL CMOP OFFICE (36C770) · 6505 · DRUGS AND BIOLOGICALS$493,607FY2024
36E79724A0005NAC PHARMACEUTICALS (36E797) · 6505 · DRUGS AND BIOLOGICALS$0FY2024
36C77024N0027NATIONAL CMOP OFFICE (36C770) · 6505 · DRUGS AND BIOLOGICALS$444,505FY2024
36F79723D0194NAC FEDERAL SUPPLY SCHEDULE (36F797) · 6505 · DRUGS AND BIOLOGICALS$0FY2023
36E79723A0011NAC PHARMACEUTICALS (36E797) · 6505 · DRUGS AND BIOLOGICALS$0FY2023
36C77023N0057NATIONAL CMOP OFFICE (36C770) · 6505 · DRUGS AND BIOLOGICALS$529,877FY2023

Other recipients under 6505 from 241-NETWORK CONTRACT OFFICE 01 (36C241) (most recent first)

AwardRecipientOfficeNet obligationsFY
36C24126P0328CARDINAL HEALTH 414, LLC241-NETWORK CONTRACT OFFICE 01 (36C241)$999,797FY2026
36C24126F0121MCKESSON CORPORATION241-NETWORK CONTRACT OFFICE 01 (36C241)$16,333FY2026
36C24126F0112VANTIVE US HEALTHCARE LLC241-NETWORK CONTRACT OFFICE 01 (36C241)$545,567FY2026
36C24126N0603AMERICAN NATIONAL RED CROSS, THE241-NETWORK CONTRACT OFFICE 01 (36C241)$1,998,719FY2026
36C24126F0109BOSTON SCIENTIFIC CORP241-NETWORK CONTRACT OFFICE 01 (36C241)$304,950FY2026

Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA24115J0755_3600_V797P5233B_3600 · retrieved 2026-09-26.